PCS499 - Processa Pharmaceuticals
CoNCERT Pharmaceuticals: ROTH Conference (Concert Pharma) - Mar 11, 2014 - Anticipated request for end of P2 meeting with the FDA for diabetic kidney disease in mid-2014 
Anticipated FDA event • Renal Disease
http://wsw.com/webcast/roth28/cnce/
 
Mar 11, 2014
 
.
 
c786e957-2e18-49d8-80d8-a7f6963f3583.jpg